In addition to the Wnt/beta-catenin signaling pathway, the PI3K/Akt/mTOR pathway is activated in 30–40% of breast cancer cases and there is evidence of metastasis, angiogenesis, and therapy resistance [128]. Here, CTNNB1 is linked to breast cancer.